These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17855717)

  • 1. Litigating the science of breast cancer treatment.
    Jacobson PD; Rettig RA; Aubry WM
    J Health Polit Policy Law; 2007 Oct; 32(5):785-818. PubMed ID: 17855717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approach to administrative medical decision-making: evidence-based medicine using high dose chemotherapy/bone marrow transplant for breast cancer.
    Lucey C; Westphal JR
    South Med J; 1998 Feb; 91(2):196-201. PubMed ID: 9496875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in approval by insurance companies of coverage for autologous bone marrow transplantation for breast cancer.
    Peters WP; Rogers MC
    N Engl J Med; 1994 Feb; 330(7):473-7. PubMed ID: 8289855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The controversy over high-dose chemotherapy with autologous bone marrow transplant for breast cancer.
    Mello MM; Brennan TA
    Health Aff (Millwood); 2001; 20(5):101-17. PubMed ID: 11558695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABMT and breast cancer.
    Firshein J
    Healthplan; 1999; 40(4):30-3, 35-7. PubMed ID: 10557735
    [No Abstract]   [Full Text] [Related]  

  • 6. ABMT and breast cancer: what have we learned?
    Brown E
    Physician Exec; 1999; 25(4):86-8. PubMed ID: 10557495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives. Indefinite results in ABMT (autologous bone marrow transplantation) trials add to challenges for practice standards, quality assurance in cancer care.
    Cunningham R
    Med Health; 1999 Apr; 53(16):suppl 1-4. PubMed ID: 10387749
    [No Abstract]   [Full Text] [Related]  

  • 8. How courts view experimental treatments.
    Gallinari KL
    J Health Care Benefits; 1994; 3(5):37-43. PubMed ID: 10133661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer coverage. Why are insurers paying for this "experimental" therapy?
    Med Econ; 1996 Sep; 73(17):38. PubMed ID: 10161873
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental medical treatments: who should decide coverage?
    Collins JC
    Spec Law Dig Health Care Law; 1998 Jan; (226):9-45. PubMed ID: 10176412
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluating promising new treatments for life-threatening disease: implications of the HDC/ABMT experience for treating breast cancer.
    Edwards S
    Find Brief; 2005 Jan; 8(1):1-3. PubMed ID: 15672527
    [No Abstract]   [Full Text] [Related]  

  • 12. Current legal intervention regarding "experimental" treatments must be changed: an analysis of high doses of chemotherapy with autologous bone marrow transplantation for breast cancer patients.
    Smayda E
    J Law Health; 1998-1999; 13(2):257-80. PubMed ID: 10947396
    [No Abstract]   [Full Text] [Related]  

  • 13. Health insurance: coverage of autologous bone marrow transplantation for breast cancer.
    Jaggar SF
    Oncology (Williston Park); 1996 Sep; 10(9):1329-32, 1337-8, 1340 passim. PubMed ID: 8882925
    [No Abstract]   [Full Text] [Related]  

  • 14. The soul of an HMO.
    Larson E
    Time; 1996 Jan; 147(4):44-52. PubMed ID: 10153782
    [No Abstract]   [Full Text] [Related]  

  • 15. When an insurer calls your treatment experimental.
    Holoweiko M
    Med Econ; 1995 Sep; 72(17):171-2, 175-6, 178-82. PubMed ID: 10151340
    [No Abstract]   [Full Text] [Related]  

  • 16. Two views on HDCT-ABMT breast cancer treatment controversy. Too experimental for insurers--or just too expensive?
    Carter RD; Coleman DM; Bennett JE
    Healthspan; 1992 Jan; 9(1):10-5. PubMed ID: 10117134
    [No Abstract]   [Full Text] [Related]  

  • 17. Survival impact of integrative cancer care in advanced metastatic breast cancer.
    Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J
    Breast J; 2009; 15(4):357-66. PubMed ID: 19470134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in insurance coverage for autologous bone marrow transplantation for breast cancer.
    Wingard JR
    N Engl J Med; 1994 Aug; 331(5):330; author reply 330-1. PubMed ID: 8022452
    [No Abstract]   [Full Text] [Related]  

  • 19. High-dose chemotherapy with autologous bone marrow transplantation for the treatment of metastatic breast cancer.
    Eddy DM
    J Clin Oncol; 1992 Apr; 10(4):657-70. PubMed ID: 1285731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in insurance coverage for autologous bone marrow transplantation for breast cancer.
    Cutler CM; Udvarhelyi IS; Winkenwerder W
    N Engl J Med; 1994 Aug; 331(5):329-30. PubMed ID: 8022449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.